Competing hypotheses of AD progression include the amyloid cascade hypothesis, where Aβ and tau accumulation drive mitochondrial dysfunction, and the mitochondrial cascade hypothesis, which posits that Aβ deposition occurs secondary to mitochondrial dysfunction, which is the initial trigger of AD [137,138]. The gene discussed is MAPT; the disease is Alzheimer disease.